Tags

Type your tag names separated by a space and hit enter

Visceral leishmaniasis in a patient with active HBV/HDV co-infection.

Abstract

Visceral leishmaniasis (VL) is an endemic infection in different regions of Italy and Europe caused by protozoan parasites of the genus Leishmania, transmitted to humans through sandflies bites. Reactivation after Solid Organ Transplantation was reported and could be a risk of organ rejection. A 48 years old woman was admitted to our hospital, complaining about low-grade fever, loss of weight and new onset pancytopenia in a known cirrhosis due to active HBV/HDV co-infection. Clinical, microbiological and anatomo-pathological elements were pivotal to define the diagnosis of VL and started an appropriate anti-infective treatment. After that she underwent liver transplantation and a therapy for VL was set. No signs of reactivation were reported in the 14 months of follow-up.

Authors+Show Affiliations

Department of Medical Sciences, Infectious Diseases, University of Turin, Italy. Electronic address: tommaso.lupia89@gmail.com.Department of Medical Sciences, Infectious Diseases, University of Turin, Italy.Department of Medical Sciences, Infectious Diseases, University of Turin, Italy.Department of Medical Sciences, Infectious Diseases, University of Turin, Italy.Department of Medical Sciences, Infectious Diseases, University of Turin, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31416795

Citation

Lupia, Tommaso, et al. "Visceral Leishmaniasis in a Patient With Active HBV/HDV Co-infection." Journal of Infection and Public Health, 2019.
Lupia T, Corcione S, Boglione L, et al. Visceral leishmaniasis in a patient with active HBV/HDV co-infection. J Infect Public Health. 2019.
Lupia, T., Corcione, S., Boglione, L., Cariti, G., & De Rosa, F. G. (2019). Visceral leishmaniasis in a patient with active HBV/HDV co-infection. Journal of Infection and Public Health, doi:10.1016/j.jiph.2019.07.026.
Lupia T, et al. Visceral Leishmaniasis in a Patient With Active HBV/HDV Co-infection. J Infect Public Health. 2019 Aug 13; PubMed PMID: 31416795.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Visceral leishmaniasis in a patient with active HBV/HDV co-infection. AU - Lupia,Tommaso, AU - Corcione,Silvia, AU - Boglione,Lucio, AU - Cariti,Giuseppe, AU - De Rosa,Francesco G, Y1 - 2019/08/13/ PY - 2019/02/27/received PY - 2019/07/09/revised PY - 2019/07/28/accepted PY - 2019/8/17/entrez KW - HBV KW - HDV KW - Leishmaniasis KW - Liposomial amphotericin B KW - Pancytopenia KW - Solid organ transplant JF - Journal of infection and public health JO - J Infect Public Health N2 - Visceral leishmaniasis (VL) is an endemic infection in different regions of Italy and Europe caused by protozoan parasites of the genus Leishmania, transmitted to humans through sandflies bites. Reactivation after Solid Organ Transplantation was reported and could be a risk of organ rejection. A 48 years old woman was admitted to our hospital, complaining about low-grade fever, loss of weight and new onset pancytopenia in a known cirrhosis due to active HBV/HDV co-infection. Clinical, microbiological and anatomo-pathological elements were pivotal to define the diagnosis of VL and started an appropriate anti-infective treatment. After that she underwent liver transplantation and a therapy for VL was set. No signs of reactivation were reported in the 14 months of follow-up. SN - 1876-035X UR - https://www.unboundmedicine.com/medline/citation/31416795/Visceral_leishmaniasis_in_a_patient_with_active_HBV/HDV_co-infection L2 - https://linkinghub.elsevier.com/retrieve/pii/S1876-0341(19)30261-8 DB - PRIME DP - Unbound Medicine ER -